Regonat - Regorafenib 40mg 28 Tablets (Stivarga) - Anticancer Medication

REGORAFENIB 40 mg (Regonat) x 28 Tablets

$425.00 $175.00
image Prescription Required

Regonat contains Regorafenib 40 mg, a targeted chemotherapy medicine used to treat certain types of cancers, including colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).

Generic Name Regorafenib
Manufacturer Natco Pharma Ltd
Packing 28 Tablets
Prescribed For Colorectal Cancer, Liver Cancer and GIST
Availability In Stock
Shipping to USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Contact us on WhatsApp

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Benefits of REGORAFENIB 40 mg

  • Targets and slows cancer cell activity
  • Supports effective cancer management
  • Used in advanced cancer therapy
  • Helps control disease development
  • May support long-term treatment goals
  • Supports better health outcomes

Side Effects

  • Fatigue or weakness
  • Loss of appetite
  • Weight loss
  • Diarrhea
  • Mouth sores
  • High blood pressure
  • Hand-foot skin reaction
  • Nausea and vomiting
  • Voice changes
  • Increased liver enzymes

Caution:

  • Take exactly as prescribed.
  • Do not skip or stop doses.
  • Inform your doctor of liver, heart, or kidney problems.
  • Monitor blood pressure and liver function regularly.
  • Avoid pregnancy during treatment.
  • Do not share medication.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.

Author

Reviewed By

Dr. Abhinav Narang

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.

Need assistance? Chat with us